Neonc Technologies Holdings NTHI
NASDAQ NTHI
$4.68 +0.12 (+2.52%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neonc Technologies Holdings (NTHI) Shares Outstanding (2024 - 2026)

Neonc Technologies Holdings (NTHI) posted quarterly Shares Outstanding (Entity) of $24.8 million for Q1 2026, up 30.48% year-over-year from $19.0 million in Q1 2025, and up 12.89% quarter-over-quarter from $22.0 million in Q4 2025.

Neonc Technologies Holdings (NTHI) Shares Outstanding (2024 - 2026) Analysis & Trends

Neonc Technologies Holdings (NTHI) has reported Shares Outstanding (Entity) for 3 consecutive years, with $24.8 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Shares Outstanding (Entity) rose 30.48% year-over-year to $24.8 million; the TTM figure through Mar 2026 stood at $24.8 million (up 30.48% YoY), while the FY2025 annual figure was $22.0 million, up 21.56% from the prior year.
  • Shares Outstanding (Entity) grew to $24.8 million in Q1 2026 per NTHI's latest filing, from $22.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $24.8 million in Q1 2026 and bottomed at $16.6 million in Q1 2024.
  • Historically, Shares Outstanding (Entity) has averaged $19.4 million across 3 years, with a median of $19.0 million in 2025.
  • Annual changes were most pronounced in 2025 — Shares Outstanding (Entity) grew 6.71% — and 2026, when it soared 30.48%.
  • Neonc Technologies Holdings' Shares Outstanding (Entity) stood at $18.1 million in 2024, then increased by 21.56% to $22.0 million in 2025, then rose by 12.89% to $24.8 million in 2026.
  • Business Quant data shows NTHI's Shares Outstanding (Entity) at $24.8 million in Q1 2026, $22.0 million in Q4 2025, and $19.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.19 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 445.06 Mn
10 Neonc Technologies Holdings 116.41 Mn 116.41 Mn - 24.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 24.66 Mn
Mar 31, 2026 23.29 Mn
Dec 31, 2025 19.40 Mn
Sep 30, 2025 19.21 Mn
Jun 30, 2025 19.03 Mn
Mar 31, 2025 18.14 Mn
Dec 31, 2024 17.34 Mn
Sep 30, 2024 17.92 Mn
Jun 30, 2024 16.64 Mn
Mar 31, 2024 16.56 Mn